SEC Form 4 · accession 0000950138-16-001236
INTERLEUKIN GENETICS INC · ILIU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
ALTICOR INC
10% Owner
PYXIS INNOVATIONS INC
10% Owner
SOLSTICE HOLDINGS INC
10% Owner
Alticor Global Holdings Inc.
10% Owner
Period of report
Jul 29, 2016
Accepted (ET)
Aug 3, 2016 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001037649
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 29, 2016 | P | 5,030,181 | $0.0994 | A | 42,595,659 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Warrant (right to buy)F1 | $0.0994 | Jul 29, 2016 | P | 5,030,181 | A | Jul 29, 2016 | Jul 29, 2023 | Common Stock | 5,030,181 | 5,030,181 | D |
Explanation of responses
- F1The reported securities are owned directly by Pyxis Innovations Inc., which is a wholly owned subsidiary of Alticor Inc., which is a wholly owned subsidiary of Solstice Holdings Inc., which is a wholly owned subsidiary of Alticor Global Holdings Inc. Alticor Inc., Solstice Holdings Inc. and Alticor Global Holdings Inc. are indirect beneficial owners of the reported securities.